G01N 33/74
Involving hormones or other non-cytokine intercellular protein regulatory factors such as growth
Official title: involving hormones {or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors}
G01N33/74 (Involving hormones or other non-cytokine intercellular protein regulatory factors such as growth) appears on 3,194 US grants and 4,084 published applications in this corpus.
Search patents in G01N- Granted patents
- 3,194
- Published applications
- 4,084
- Assignees
- 1,874
- Inventors
- 8,372
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 17 | 0 |
| 1977 | 19 | 0 |
| 1978 | 32 | 0 |
| 1979 | 12 | 0 |
| 1980 | 28 | 0 |
| 1981 | 33 | 0 |
| 1982 | 33 | 0 |
| 1983 | 22 | 0 |
| 1984 | 20 | 0 |
| 1985 | 18 | 0 |
| 1986 | 16 | 0 |
| 1987 | 32 | 0 |
| 1988 | 28 | 0 |
| 1989 | 32 | 0 |
| 1990 | 25 | 0 |
| 1991 | 31 | 0 |
| 1992 | 33 | 0 |
| 1993 | 43 | 0 |
| 1994 | 37 | 0 |
| 1995 | 29 | 0 |
| 1996 | 52 | 0 |
| 1997 | 97 | 0 |
| 1998 | 136 | 0 |
| 1999 | 80 | 0 |
| 2000 | 62 | 0 |
| 2001 | 62 | 23 |
| 2002 | 73 | 113 |
| 2003 | 60 | 196 |
| 2004 | 55 | 141 |
| 2005 | 36 | 162 |
| 2006 | 76 | 189 |
| 2007 | 68 | 181 |
| 2008 | 76 | 145 |
| 2009 | 79 | 174 |
| 2010 | 106 | 190 |
| 2011 | 126 | 176 |
| 2012 | 96 | 165 |
| 2013 | 106 | 196 |
| 2014 | 94 | 194 |
| 2015 | 122 | 217 |
| 2016 | 96 | 191 |
| 2017 | 123 | 193 |
| 2018 | 126 | 163 |
| 2019 | 103 | 152 |
| 2020 | 104 | 166 |
| 2021 | 98 | 154 |
| 2022 | 90 | 148 |
| 2023 | 64 | 126 |
| 2024 | 70 | 107 |
| 2025 | 68 | 124 |
| 2026 | 50 | 98 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Monoclonal antibody and polyclonal antibody and oxytocin quantification method based on same29 Sep 2026US 12,748,117 B2Universidad De Murcia
- Humanized anti-TrkA antibodies and uses thereof22 Sep 2026US 12,742,012 B2Sunshine Lake Pharma Co., Ltd.
- Method for monitoring autoimmune disease8 Sep 2026US 12,730,106 B2The Regents of the University of Micigan
- Compositions and methods for treating heart failure18 Aug 2026US 12,708,658 B2Zensun (Shanghai) Science & Technology, Co., Ltd.
- Heart failure marker4 Aug 2026US 12,699,104 B2National University Corporation Kagawa University
- Methods of determining glucose hypometabolism-induced energy crisis and treatments thereof8 Oct 2026US 2026/0306018 A1Senovia Biosciences LLC
- Using vefg165 fragments as a novel biomarker of inflammation to diagnose and guide medical care and treatments8 Oct 2026US 2026/0308202 A1Children's Medical Center Corporation
- Compositions and methods for treating diseases and conditions associated with activation of the nlrp3 inflammasome1 Oct 2026US 2026/0297180 A1
- Engineered antibody fusion proteins with modulable binding constants and their applications1 Oct 2026US 2026/0297181 A1The University of North Carolina at Chapel Hill
- Oxyntomodulin binding molecules, and uses thereof1 Oct 2026US 2026/0297182 A1Eli Lilly and Company
Most cited
By later US patents
- Methods for identifying nucleic acid ligands856US 5,270,163 AUniversity Research Corporation · 1993
- Enrichment method for variant proteins having altered binding properties, M13 phagemids, and growth hormone variants660US 5,750,373 AGenentech, Inc. · 1998
- Monovalent phage display562US 5,821,047 AGenentech, Inc. · 1998
- Nucleic acid ligands561US 5,475,096 AUniversity Research Corporation · 1995
- In vivo biosensor apparatus and method of use496US 6,673,596 B1The University of Tennessee Research Corporation · 2004